Mawer Investment Management Ltd. trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.0% in the 3rd quarter, Holdings Channel.com reports. The firm owned 2,179,775 shares of the healthcare conglomerate’s stock after selling 20,921 shares during the period. UnitedHealth Group comprises approximately 5.8% of Mawer Investment Management Ltd.’s portfolio, making the stock its 4th biggest holding. Mawer Investment Management Ltd.’s holdings in UnitedHealth Group were worth $1,274,471,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also recently added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD raised its stake in shares of UnitedHealth Group by 0.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock worth $12,893,331,000 after buying an additional 94,641 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of UnitedHealth Group by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock valued at $4,094,247,000 after buying an additional 35,533 shares during the period. International Assets Investment Management LLC raised its position in UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after buying an additional 5,290,025 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after acquiring an additional 880,183 shares during the last quarter. Finally, Ameriprise Financial Inc. lifted its position in shares of UnitedHealth Group by 0.6% in the 2nd quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock worth $1,920,039,000 after acquiring an additional 21,149 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.
UnitedHealth Group Stock Performance
Shares of UNH opened at $586.62 on Monday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock has a market capitalization of $539.85 billion, a price-to-earnings ratio of 38.58, a price-to-earnings-growth ratio of 1.74 and a beta of 0.58. The stock’s 50-day simple moving average is $582.84 and its 200 day simple moving average is $549.98.
UnitedHealth Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.43%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.
Analysts Set New Price Targets
UNH has been the topic of several recent research reports. Truist Financial restated a “buy” rating and issued a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Stephens reduced their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. UBS Group decreased their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Finally, HSBC downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Three investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $615.53.
Read Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- Quiet Period Expirations Explained
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- How to Plot Fibonacci Price Inflection Levels
- Applied Materials Market Capitulates: Now is the Time to Buy
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Ultra-High Dividend Yield Stocks for the New Year
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.